Item 16. 10-K Summary

2K characters. Original on sec.gov · Markdown

Item 16. 10-K Summary

| --- | --- |

None

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ZIMMER BIOMET HOLDINGS, INC.

	By:	/s/ Bryan C. Hanson
Dated: February 26, 2019		Bryan C. Hanson
		President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SIGNATURE	TITLE	DATE
/s/ Bryan C. Hanson	President, Chief Executive Officer and Director	February 26, 2019
Bryan C. Hanson	(Principal Executive Officer)

/s/ Daniel P. Florin	Executive Vice President and Chief Financial Officer	February 26, 2019
Daniel P. Florin	(Principal Financial and Accounting Officer)

/s/ Christopher B. Begley	Director	February 26, 2019
Christopher B. Begley

/s/ Betsy J. Bernard	Director	February 26, 2019
Betsy J. Bernard

/s/ Gail K. Boudreaux	Director	February 26, 2019
Gail K. Boudreaux

/s/ Michael J. Farrell	Director	February 26, 2019
Michael J. Farrell

/s/ Larry C. Glasscock	Director	February 26, 2019
Larry C. Glasscock

/s/ Robert A. Hagemann	Director	February 26, 2019
Robert A. Hagemann

/s/ Arthur J. Higgins	Director	February 26, 2019
Arthur J. Higgins

/s/ Maria Teresa Hilado	Director	February 26, 2019
Maria Teresa Hilado

/s/ Syed Jafry	Director	February 26, 2019
Syed Jafry

/s/ Michael W. Michelson	Director	February 26, 2019
Michael W. Michelson

Previous: Item 15. Exhibits and Financial Statement Schedules